These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
546 related articles for article (PubMed ID: 16986130)
1. Acquired von Willebrand syndrome: diagnostic problems and therapeutic options. Eikenboom JC; Tjernberg P; Van Marion V; Heering KJ Am J Hematol; 2007 Jan; 82(1):55-8. PubMed ID: 16986130 [TBL] [Abstract][Full Text] [Related]
2. Use of intravenous immunoglobulin in patients with acquired von Willebrand syndrome. Federici AB Hum Immunol; 2005 Apr; 66(4):422-30. PubMed ID: 15866707 [TBL] [Abstract][Full Text] [Related]
3. Diagnosis and therapeutic management in a patient with type 2B-like acquired von Willebrand syndrome. Karger R; Weippert-Kretschmer M; Budde U; Kretschmer V Blood Coagul Fibrinolysis; 2011 Mar; 22(2):144-7. PubMed ID: 21178586 [TBL] [Abstract][Full Text] [Related]
4. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management. Michiels JJ; Budde U; van der Planken M; van Vliet HH; Schroyens W; Berneman Z Best Pract Res Clin Haematol; 2001 Jun; 14(2):401-36. PubMed ID: 11686107 [TBL] [Abstract][Full Text] [Related]
5. Acquired von Willebrand syndrome: features and management. Mohri H Am J Hematol; 2006 Aug; 81(8):616-23. PubMed ID: 16823821 [TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of von Willebrand factor and its propeptide in plasma in acquired von Willebrand syndrome. van Genderen PJ; Boertjes RC; van Mourik JA Thromb Haemost; 1998 Sep; 80(3):495-8. PubMed ID: 9759633 [TBL] [Abstract][Full Text] [Related]
7. Causes, etiology and diagnosis of acquired von Willebrand disease: a prospective diagnostic workup to establish the most effective therapeutic strategies. Sucker C; Michiels JJ; Zotz RB Acta Haematol; 2009; 121(2-3):177-82. PubMed ID: 19506364 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic studies with FVIII/von Willebrand factor concentrate can be a diagnostic tool to distinguish between subgroups of patients with acquired von Willebrand syndrome. Luboshitz J; Lubetsky A; Schliamser L; Kotler A; Tamarin I; Inbal A Thromb Haemost; 2001 May; 85(5):806-9. PubMed ID: 11372672 [TBL] [Abstract][Full Text] [Related]
9. Acquired von Willebrand disease--hemostatic management of major orthopedic surgery with high-dose immunoglobulin, desmopressin, and continuous factor concentrate infusion. Frank RD; Kunz D; Wirtz DC Am J Hematol; 2002 May; 70(1):64-71. PubMed ID: 11994985 [TBL] [Abstract][Full Text] [Related]
10. [Acquired von Willebrand syndrome]. de Lange DW; Fijnheer R; Wittebol S Ned Tijdschr Geneeskd; 2003 Sep; 147(37):1808-11. PubMed ID: 14526622 [TBL] [Abstract][Full Text] [Related]
11. Diagnosis and management of acquired von Willebrand syndrome. Federici AB; Mannucci PM Clin Adv Hematol Oncol; 2003 Mar; 1(3):169-75. PubMed ID: 16224398 [TBL] [Abstract][Full Text] [Related]
12. Acquired von Willebrand disease: management of labor and delivery with intravenous dexamethasone, continuous factor concentrate, and immunoglobulin infusion. Lipkind HS; Kurtis JD; Powrie R; Carpenter MW Am J Obstet Gynecol; 2005 Jun; 192(6):2067-70. PubMed ID: 15970901 [TBL] [Abstract][Full Text] [Related]
13. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio. Gadisseur A; Berneman Z; Schroyens W; Michiels JJ Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359 [TBL] [Abstract][Full Text] [Related]
14. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease. Shihong I; Morris D; Konkle BA Haemophilia; 2009 Jan; 15(1):131-4. PubMed ID: 18976254 [TBL] [Abstract][Full Text] [Related]
15. Immune-mediated etiology of acquired von Willebrand syndrome in systemic lupus erythematosus and in benign monoclonal gammopathy: therapeutic implications. Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; Budde U; van Vliet HH Semin Thromb Hemost; 2006 Sep; 32(6):577-88. PubMed ID: 16977568 [TBL] [Abstract][Full Text] [Related]
16. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Nichols WL; Hultin MB; James AH; Manco-Johnson MJ; Montgomery RR; Ortel TL; Rick ME; Sadler JE; Weinstein M; Yawn BP Haemophilia; 2008 Mar; 14(2):171-232. PubMed ID: 18315614 [TBL] [Abstract][Full Text] [Related]
17. Association of acquired von Willebrand syndrome with AL amyloidosis. Kos CA; Ward JE; Malek K; Sanchorawala V; Wright DG; O'Hara C; Connors L; Skinner M; Seldin DC Am J Hematol; 2007 May; 82(5):363-7. PubMed ID: 17205535 [TBL] [Abstract][Full Text] [Related]
18. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3. Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493 [TBL] [Abstract][Full Text] [Related]
19. Guidelines for the evaluation of intravenous desmopressin and von Willebrand factor/factor VIII concentrate in the treatment and prophylaxis of bleedings in von Willebrand disease types 1, 2, and 3. Michiels JJ; Gadisseur A; van der Planken M; Schroyens W; van de Velden A; Berneman Z Semin Thromb Hemost; 2006 Sep; 32(6):636-45. PubMed ID: 16977574 [TBL] [Abstract][Full Text] [Related]
20. Acquired von Willebrand syndrome: data from an international registry. Federici AB; Rand JH; Bucciarelli P; Budde U; van Genderen PJ; Mohri H; Meyer D; Rodeghiero F; Sadler JE; Thromb Haemost; 2000 Aug; 84(2):345-9. PubMed ID: 10959711 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]